| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.12 | 7e-05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.23 | 9e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |